CRL
Charles River Laboratories
Description:
Charles River Laboratories International, Inc. (CRL) is a leading global provider of critical products and services designed for the pharmaceutical, biotechnology, and medical device industries. The company excels in offering a complete range of preclinical and clinical laboratory services, alongside cutting-edge gene and cell therapy solutions that significantly bolster research and development efforts. With a strong emphasis on innovation and adherence to regulatory standards, Charles River plays a vital role in facilitating efficient drug development processes, thereby contributing to the advancement of healthcare solutions on a global scale.
Industry:
DIAGNOSTICS & RESEARCH
Address:
251 BALLARDVALE STREET, WILMINGTON, MA, UNITED STATES, 01887
Fiscal year end:
December
Market capitalization:
$8 Billion
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
+176%
How much will you get:
$2,760
Prices dates:
30-10-2015: $65.24 and 31-10-2025: $180.07